Case report identifies thrombocytopenia from hemodialysis systems in ESKD, suggesting filter substitution improves outcomes.
A BSTRACT We report the case of an 81-year-old man with end-stage kidney disease (ESKD) who was admitted to the intensive care unit with severe gastroenteritis and hypovolemic shock. During hospitalization, he underwent hemodialysis via a subclavian catheter using the NxStage system, which was followed by a progressive daily decline in platelet count. Despite platelet transfusions and corticosteroid therapy, thrombocytopenia persisted. A comprehensive evaluation excluded secondary causes, such as infection, drug-induced thrombocytopenia, and disseminated intravascular coagulation. Upon switching to a different hemodialysis system utilizing the Diacap 18NR filter (manufacturer: B. Braun), platelet counts improved significantly over the following sessions. This case highlights the importance of recognizing dialyzer-associated thrombocytopenia and demonstrates that prompt identification and substitution of the implicated membrane can result in rapid hematologic recovery and improved patient outcomes.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: